Phase 3 Study Of The Efficacy And Safety Of Iptacopan (Lnp023), An Oral Factor B Inhibitor, In Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (Pnh) Naive To Complement Inhibitor Therapy
Iptacopan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase 3 Study Of The Efficacy And Safety Of Iptacopan (Lnp023), An Oral Factor B Inhibitor, In Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (Pnh) Naive To Complement Inhibitor Therapy ### Output: Iptacopan